v3.26.3
Asset Purchases and Sales (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended
Apr. 30, 2026
Oct. 30, 2024
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Asset Acquisition [Line Items]          
Convertible note       $ 2,687 $ 2,687
Nex Gel License Agreement [Member] | Subsequent Event [Member]          
Asset Acquisition [Line Items]          
Net proceeds $ 4,800        
Deferred payment     $ 600    
[custom:MilestonePayments] 20,000        
[custom:FirstMilestonePayments] 2,500        
Revenues 25,000        
Nex Gel License Agreement [Member] | Subsequent Event [Member] | Minimum [Member]          
Asset Acquisition [Line Items]          
Revenues 15,000        
Nex Gel License Agreement [Member] | Subsequent Event [Member] | Helena Global Investment Opportunities Ltd [Member]          
Asset Acquisition [Line Items]          
Pay sales commissions 2,500        
Nex Gel License Agreement [Member] | Subsequent Event [Member] | Sequence Life Sciences Inc [Member]          
Asset Acquisition [Line Items]          
Pay sales commissions 2,500        
Sequence LifeScience Inc [Member]          
Asset Acquisition [Line Items]          
Asset acquisition   $ 5,500      
Cash payment   1,500      
Monthly milestone payments   $ 4,000      
Net sales percentage   20.00%      
Accured milestone payments       $ 3,127 $ 3,127
Nex Gel Inc. [Member] | Nex Gel License Agreement [Member] | Subsequent Event [Member]          
Asset Acquisition [Line Items]          
Asset acquisition 13,300        
Pay sales commissions 2,900        
Convertible note $ 5,000